Anixa Biosciences Inc
(ANIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,785 | -6,470 | -3,290 | -9,930 | -7,209 |
| Depreciation Amortization | 28 | 25 | 13 | 46 | 34 |
| Accounts receivable | -140 | 52 | -121 | -224 | -288 |
| Other Working Capital | -447 | 160 | -292 | -1,060 | -572 |
| Other Operating Activity | 3,936 | 2,468 | 1,381 | 4,959 | 3,795 |
| Operating Cash Flow | $-6,408 | $-3,765 | $-2,309 | $-6,209 | $-4,240 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,409 | 685 | 129 | -5,602 | -5,009 |
| Investing Cash Flow | $3,409 | $685 | $129 | $-5,602 | $-5,009 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,309 | 131 | 67 | 366 | 87 |
| Other Financing Activity | 0 | 3,029 | 2,196 | 0 | 0 |
| Financing Cash Flow | $3,309 | $3,160 | $2,263 | $366 | $87 |
| Beginning Cash Position | 915 | 915 | 915 | 12,360 | 12,360 |
| End Cash Position | 1,225 | 995 | 998 | 915 | 3,198 |
| Net Cash Flow | $310 | $80 | $83 | $-11,445 | $-9,162 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,408 | -3,765 | -2,309 | -6,209 | -4,240 |
| Free Cash Flow | -6,408 | -3,765 | -2,309 | -6,209 | -4,240 |